Does MACITENTAN Cause Infusion site extravasation? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Infusion site extravasation have been filed in association with MACITENTAN (OPSYNVI). This represents 0.0% of all adverse event reports for MACITENTAN.
11
Reports of Infusion site extravasation with MACITENTAN
0.0%
of all MACITENTAN reports
2
Deaths
5
Hospitalizations
How Dangerous Is Infusion site extravasation From MACITENTAN?
Of the 11 reports, 2 (18.2%) resulted in death, 5 (45.5%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which MACITENTAN Alternatives Have Lower Infusion site extravasation Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE